LONDON, Jan. 14, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of KLOXXADO® naloxone HCl nasal spray 8 mg in the U.S....
Hence then, the article about hikma announces exclusive commercial partnership with emergent biosolutions for kloxxado naloxone hcl nasal spray 8 mg was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg )
Also on site :
- Clarks’ ‘Comfortable’ Loafers Have Shoppers Walking ‘All Day With No Fatigue,’ and They’re on Sale for $60
- We Asked 3 Disney Travel Experts for the Best Multigenerational Family Vacation Upgrade—They All Said the Same Thing
- Ted Lasso's Jason Sudeikis And Brett Goldstein Team With Sesame Street's Elmo And Oscar For Daily Affirmations — Watch Or Scram!